1. ‘International Conference on Harmonisation; Draft Guideline on Clinical Safety Data Management: Definitions and Standards for Expedited Reporting; Availability, Notice’;, Federal Register, 1993, Vol. 58, No. 130, 37408–37412.
2. CPMP ‘Biostatistical methodology in clinical trials in applications for marketing authorizations for medicinal products’, Note for Guidance, CPMP, 1993.
3. Pharmacoepidemiology in pre-approval clinical trial safety monitoring
4. Design, Monitoring, and Analysis Issues Relative to Adverse Events